Type 1_Diabetes_Saudi
1.7K posts
@Type1S
والدة لطفلين ملهمين فيهم السكري النوع الأول.ممرضة، باحثة أتمنى أن نجد علاج.Mother of 2 inspiring children with T1D, nurse, researcher,I hope we find a cure
Ohhh, imagine this: a drug that prevents low blood sugars in people with type 1 diabetes. Sounds a little impossible, right? The reality is that your liver should already do this for you by releasing stored sugar when blood sugar levels are dropping. The reason it doesn't d ...
Today, Sana Biotechnology released significant clinical data: the first person with type 1 diabetes (T1D) who received deceased donor islets engineered to evade the immune system is producing insulin without immunosuppression. Learn more here: bit.ly/40qFqyp
Submit an abstract for the 29th PSAD Scientific Meeting in Cluj, Romania from 14-16 May 2025! Deadline is: 10 December 2024 forms.gle/pQd4yKkxZwoeX3…
مؤتمر اليوم العالمي للسكري لعام ٢٠٢٤ بجامعة الملك سعود مواضيع متنوعة ومتحدثين متميزين ❇️ السبت ١٦ نوفمبر
بمناسبة اليوم العالمي للسكري فخورة بمشاركتنا في @sdm_ai ضمن #مخيم_كرز اكبر تجمع في الشرق الأوسط لمصابي السكري النوع الأول و عوائلهم مع شريكنا @Karaz_App ثقفنا و قدمنا فحوصات الشبكية لسكري العين و شاركنا في يوم مليء بالفعاليات. اشكر فريق كرز على هذا الفعالية الأكثر من رائع
Breakthrough Update: Today, Vertex announced that they are beginning their Phase 3, or pivotal trial for VX-880, a stem cell-derived islet therapy. A pivotal trial gathers the data required for an FDA submission. This therapy is for people with type 1 diabetes (T1D) and hypoglycemia unawareness and severe hypoglycemic episodes. This is a HUGE first for the #T1D community as it is the first time a scalable cure for some people with T1D is entering this phase. Breakthrough T1D and the T1D Fund are incredibly proud to have supported this work in cell therapies—a top priority for our organization. We want to congratulate our partners at Vertex and thank all the patients who have participated in clinical trials. Your courage and commitment are inspiring. Learn more here: bit.ly/48DuLTd
